M-csf for preventing or treating myeloid cytopenia and related complications following hematopoetic stem cell transplantation

The invention relates to a method for preventing or treating myeloid cytopenia and related complications such as infections in patients undergoing hematopoietic stem cell transplantation (HSCT). The approach is based on the priming of the hematopoietic stem cell graft with M-CSF following HSCT.

Keywords: Hematopoetic stem cells, transplantation, HSCT, cell therapy, regenerative medicine, cytopenia, infectious diseases, protein, polypeptide, bacterial infections, fungal infections
Patent Application number: 13 305 464.3
Inventors:
Michael SIEWEKE

You might also be interested in